Diabetes mellitus causes profound alterations in many body tissues. Microva
scular diabetic complications include diabetic neuropathy, nephropathy and
retinopathy. Nephropathy first becomes manifest with hyperfiltration and mi
croalbuminuria. These functional changes evolve over several years to a sta
ge of marked deterioration of renal function. The possible preventive measu
res are metabolic control, reduction of dietary protein intake and use of A
CE-inhibitors. Metabolic control is also important for the prevention of di
abetic retinopathy. In fact, patients with HbA1c higher than 10% have an in
creased risk of progression of retinopathy. Moreover, an accelerated progre
ssion of retinopathy has been observed in patients with systemic hypertensi
on following the onset of microalbuminuria. It has been demonstrated that d
iabetic neuropathy can also be present during childhood; therefore, it is p
ossible to detect electrophysiological abnormalities in children and adoles
cents with IDDM. Glycaemic and blood pressure control are, so far, the main
means for possible prevention or modification of the natural history of di
abetic microvascular complications. Tight glycaemic control may have benefi
cial effects for diabetic neuropathy. In addition, other preventive measure
s, such as aldose reductase inhibitors, gangliosides, neurotrophic vitamins
, etc., have been studied in the last years. However, no conclusive results
have been obtained so far.